🏅 FDA Orphan Designation
Ibtrozi
taletrectinib
Manufacturer: Nuvation Bio Inc.
Indicated for:
FDA-Approved Indications (1)
NON RARE IN EUROPE: Non-small cell lung cancerOrphan Designation
treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)
Indications & Usage
1 INDICATIONS AND USAGE IBTROZI ™ (taletrectinib) is indicated for the treatment of adult patients with locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC) [see Dosage and Administration ( 2.1 )] . IBTROZI is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic ROS1 -positive non-small cell lung cancer (NSCLC). ( 1 )
💙 Support Programs
View all →Ibtrozi
Nuvation Bio Inc.
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.